Certified by Founder Lodge
Mozart Therapeutics, Inc
United States - Seattle, WA
START UP
1 Disclosed Funding Rounds $25,000,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Mozart is developing disease-modifying therapies for autoimmune and inflammatory diseases that work by targeting a novel regulatory immune pathway.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| June, 08 ,2023 | Series A | $25,000,000 |
Eli Lilly and Company
ARCH Venture Partners
Pfizer
UPMC Enterprises
Sofinnova Partners
AbbVie
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Leadbay (YC F25) | $4,300,000 | (May 20, 2026)
bunch | $35,000,000 | (May 20, 2026)
Benji | $6,250,000 | (May 20, 2026)
Vital Signals | $15,000,000 | (May 20, 2026)
Kin Health | $9,000,000 | (May 20, 2026)
